Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 239

1.

Association between serum magnesium and risk factors of cardiovascular disease in hemodialysis patients.

Khatami MR, Mirchi E, Khazaeipour Z, Abdollahi A, Jahanmardi A.

Iran J Kidney Dis. 2013 Jan;7(1):47-52.

2.

Correlation of serum magnesium with dyslipidemia in patients on maintenance hemodialysis.

Ansari MR, Maheshwari N, Shaikh MA, Laghari MS; Darshana, Lal K, Ahmed K.

Saudi J Kidney Dis Transpl. 2012 Jan;23(1):21-5.

3.
4.
5.

Non-high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease.

Nishizawa Y, Shoji T, Kakiya R, Tsujimoto Y, Tabata T, Ishimura E, Nakatani T, Miki T, Inaba M.

Kidney Int Suppl. 2003 May;(84):S117-20. Erratum in: Kidney Int Suppl. 2003 Jun;63(6):2345-6.

PMID:
12694324
6.

Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.

Navarro JF, Mora C, Muros M, García-Idoate G.

Nephron Clin Pract. 2003;95(4):c128-35.

PMID:
14694274
7.

The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease.

Pennell P, Leclercq B, Delahunty MI, Walters BA.

Clin Nephrol. 2006 Nov;66(5):336-47.

PMID:
17140163
8.

Serum magnesium concentration and PTH levels. Is long-term chronic hypermagnesemia a risk factor for adynamic bone disease?

Navarro JF, Macía ML, Gallego E, Méndez ML, Chahín J, García-Nieto V, García JJ.

Scand J Urol Nephrol. 1997 Jun;31(3):275-80.

PMID:
9249893
9.

Cardiac troponin I in patients with chronic kidney disease treated conservatively or undergoing long-term haemodialysis.

Flisiński M, Strózecki P, Stefańska A, Zarzycka-Lindner G, Brymora A, Manitius J.

Kardiol Pol. 2007 Sep;65(9):1068-75; discussion 1076-8.

10.

Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.

Helal I, Smaoui W, Hamida FB, Ouniss M, Aderrahim E, Hedri H, Elyounsi F, Maiz HB, Abdallah TB, Kheder A.

Saudi J Kidney Dis Transpl. 2010 Jan;21(1):59-62.

11.

Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis.

Takei T, Otsubo S, Uchida K, Matsugami K, Mimuro T, Kabaya T, Akiba T, Nitta K.

Nephron Clin Pract. 2008;108(4):c278-83. doi: 10.1159/000127361. Epub 2008 Apr 22.

PMID:
18434749
12.

Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease.

Buccianti G, Baragetti I, Bamonti F, Furiani S, Dorighet V, Patrosso C.

J Nephrol. 2004 May-Jun;17(3):405-10.

PMID:
15365961
13.

The uremic dyslipidemia: a cross-sectional and longitudinal study.

Avram MM, Goldwasser P, Burrell DE, Antignani A, Fein PA, Mittman N.

Am J Kidney Dis. 1992 Oct;20(4):324-35.

PMID:
1415199
14.

Factors modulating cytosolic calcium. Role in lipid metabolism and cardiovascular morbidity and mortality in peritoneal dialysis patients.

Gadallah MF, el-Shahawy M, Andrews G, Ibrahim M, Ramdeen G, Hanna D, Gorospe W, Morkos A, Abbassian M, Moles K.

Adv Perit Dial. 2001;17:29-36.

PMID:
11510292
15.

Nonfasting non-high-density lipoprotein cholesterol is adequate for lipid management in hemodialysis patients.

Desmeules S, Arcand-Bossé JF, Bergeron J, Douville P, Agharazii M.

Am J Kidney Dis. 2005 Jun;45(6):1067-72.

PMID:
15957136
16.

Correlation between cathepsin D serum concentration and carotid intima-media thickness in hemodialysis patients.

Moallem SA, Nazemian F, Eliasi S, Alamdaran SA, Shamsara J, Mohammadpour AH.

Int Urol Nephrol. 2011 Sep;43(3):841-8. doi: 10.1007/s11255-010-9729-4. Epub 2010 Apr 13.

PMID:
20387115
17.

Low-density lipoprotein cholesterol: association with mortality and hospitalization in hemodialysis patients.

Chiang CK, Ho TI, Hsu SP, Peng YS, Pai MF, Yang SY, Hung KY, Tsai TJ.

Blood Purif. 2005;23(2):134-40. Epub 2005 Jan 21.

PMID:
15665509
18.

Atherogenic lipid profile and lipoprotein(a) in relation to serum albumin in haemodialysis patients.

Yang WS, Kim SB, Min WK, Park S, Lee MS, Park JS.

Nephrol Dial Transplant. 1995;10(9):1668-71.

PMID:
8559487
19.

Lipid parameters including lipoprotein (a) in patients undergoing CAPD and hemodialysis.

Siamopoulos KC, Elisaf MS, Bairaktari HT, Pappas MB, Sferopoulos GD, Nikolakakis NG.

Perit Dial Int. 1995 Oct-Dec;15(8):342-7.

20.

Age-related decline in serum parathyroid hormone in maintenance hemodialysis patients is independent of inflammation and dietary nutrient intake.

Mehrotra R, Supasyndh O, Berman N, Kaysen G, Hurst L, Leonardi M, Das D, Kopple JD.

J Ren Nutr. 2004 Jul;14(3):134-42.

PMID:
15232791
Items per page

Supplemental Content

Write to the Help Desk